DARA Biosciences (DARA +8.5%) pops after signing an exclusive agreement with Uman Pharma for...

|By:, SA News Editor

DARA Biosciences (DARA +8.5%) pops after signing an exclusive agreement with Uman Pharma for U.S. commercialization rights to its newly licensed anticancer-agent gemcitabine.